Growth Metrics

Carlsmed (CARL) FCF Margin (2024 - 2026)

Carlsmed posted quarterly FCF Margin of 81.5% for Q1 2026, up 6.0% year-on-year from 76.88% in Q1 2025, and down 129.12% on a QoQ basis from 35.57% in Q4 2025.

Carlsmed (CARL) has 3 years of FCF Margin data on file, last reported at 81.5% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin rose 6.0% year-over-year to 81.5%; the trailing twelve-month figure through Mar 2026 stood at 61.03% (up 103.0% YoY), and the FY2025 full-year result was 58.64%, up 3511.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 81.5%, down from 35.57% in the prior quarter.
  • Across five years, FCF Margin topped out at 35.57% in Q4 2025 and bottomed at 115.81% in Q3 2024.
  • The 3-year median for FCF Margin is 65.92% (2025), against an average of 69.16%.
  • The widest annual swing landed in 2025, when FCF Margin surged 4989 bps; it then rose 6 bps in 2026.
  • A 3-year view of FCF Margin shows it stood at 43.41% in 2024, then grew by 18 bps to 35.57% in 2025, then slumped by 129 bps to 81.5% in 2026.
  • The last three FCF Margin figures came in at 81.5% (Q1 2026), 35.57% (Q4 2025), and 65.92% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 11.94%
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 3.30%
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 23.01%
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 23.62%
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 73.79%
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 22.17%
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 17.24%
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -8.19%
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 13.57%
10 Carlsmed 298.68 Mn 201.48 Mn 12.43 Mn -81.50%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -81.50%
Dec 31, 2025 -35.57%
Sep 30, 2025 -65.92%
Jun 30, 2025 -60.39%
Mar 31, 2025 -81.56%
Dec 31, 2024 -43.41%
Sep 30, 2024 -115.81%